Leadership, Vision and Growth Copyright 2014 LED Medical
Diagnostics Inc. April 2014
Slide 2
Forward Looking Statements Certain information contained in
this presentation of LED Medical Diagnostics Inc. (the Company)
constitutes forward-looking statements within the meaning of
securities laws. Actual events or results could differ materially
from expectations and projections. Forward- looking statements
include, among other things, statements relating to expected
growth, potential market size and market share, expected revenues
and margins, introduction of new products, results of operations,
performance, business prospects and realization of cost savings.
Forward-looking statements are based on the opinions and estimates
of management at the date the statements are made, and are subject
to a variety of risks and uncertainties and other factors that
could cause actual events or results to differ materially from
those projected in the forward- looking statements. These risks and
other factors include, among other things, availability of funds,
general economic, market and business conditions, competitor risks,
distributor risks, intellectual property risks, regulatory
approvals and other risks described in the Companys Annual
Information Form available at www.sedar.com. Except as required by
law, the Company disclaims any intention or obligation to update or
revise the forward-looking information, whether as a result of new
information, future events or otherwise. The forward-looking
statements in this document are provided for the limited purpose of
enabling potential investors to evaluate an investment in the
securities of the Company. Readers are cautioned that such
statements may not be appropriate, and should not be used, for
other purposes. Nothing in this presentation should be construed as
either an offer to sell or a solicitation of an offer to buy or
sell securities in any jurisdiction. Copyright 2014 LED Medical
Diagnostics Inc. | 2
Slide 3
Who We Are Genesis as the developer of the worlds leading
adjunctive device for oral mucosal disease (including cancer)
Becoming a comprehensive digital imaging technology supplier
Positioned to become the North American leader in the dental
imaging category Copyright 2014 LED Medical Diagnostics Inc. |
3
Slide 4
Proven Executive Management Dr. David Gane, DDS CEO
High-achieving corporate strategist in dental imaging industry
Various roles as CEO, President, and VP Has demonstrated abilities
to introduce new products to achieve ambitious revenue and
profitability goals while creating high-functioning and driven
teams. www.linkedin.com/in/dgane Copyright 2014 LED Medical
Diagnostics Inc. | 4
Slide 5
Proven Executive Management Lamar Roberts President, LED
Imaging Senior sales and marketing executive Demonstrated success
in leading growth in Dental Technology companies Demonstrated
ability to navigate companies from their early stages to becoming
an industry leader. Proven leadership in public companies.
Effective in leading mergers, acquisitions, integrations, sales,
marketing, product management, operations and admin Copyright 2014
LED Medical Diagnostics Inc. | 5
Slide 6
Where We Came From Carestream Dental Revenue $2.5B Dental
revenues: $500MM 7000 employees who serve customers in 150
countries Dental Division: 1200 employees Products in 90 percent of
hospitals and dental practices worldwide Copyright 2014 LED Medical
Diagnostics Inc. | 6
Slide 7
Our Future We are building a high-value dental imaging company
by growing our VELscope technology foundation while adding
complementary diagnostic imaging products that leverage our
established brand. Copyright 2014 LED Medical Diagnostics Inc. |
7
Slide 8
VELscope Vx : How It Works An Easy-to-Use Handheld Device
Copyright 2014 LED Medical Diagnostics Inc. | 8
Slide 9
The VELscope Vx Scan Early Detection of Occult Lesions View
with the Naked Eye View Using VELscope VX (biopsy confirmed oral
cancer) Copyright 2014 LED Medical Diagnostics Inc. | 9
Slide 10
Dental Imaging Opportunity Imaging fundamental to Diagnosis
& Tx Planning Explosive Growth in Dental Implant & CAD CAM
Ensures Market Recovery and Fuels Esthetic Sales Imaging moving
from realm of pure diagnosis to guided imaging treatments The
global market for dental imaging systems is predicted to reach over
$2.3B by 2022 Copyright 2014 LED Medical Diagnostics Inc. | 10
Slide 11
New LED Imaging Division We have recognized an unmet demand for
new types of digital imaging technology in the dental market.
Driven by: Demand for cosmetic dental procedures such as
orthodontics, composites, veneers and crowns Shift from film-based
systems to faster, more efficient and higher quality digital
imaging solutions. Founded LED Imaging Division in April 2014
Copyright 2014 LED Medical Diagnostics Inc. | 11
Slide 12
Imaging Product Strategy Copyright 2014 LED Medical Diagnostics
Inc. | 12
Slide 13
New Partnership with Ray Co. Signed with Ray Co.- Samsung
subsidiary in April 2014 Best-of-class multi-function digital
extraoral imaging system RAYSCAN High demand two systems already
in-situ (six figure price per system) Copyright 2014 LED Medical
Diagnostics Inc. | 13
Slide 14
New Partnership with BC Cancer Agency / Genome BC LED Medical
/BC Cancer Agency /Genome BC: create/commercialize groundbreaking
Oral Cancer RiskAssessment Test Technology to build upon $10MM of
National Institute of Health and TFRI Research Funding Test is a
first of its kind for oral cancer based on a quantifiable genetic
phenomenon known as Loss of Heterozygosity, or LOH. Measures
specific genetic changes shown to predict aggressive tumour growth
- potential to lower oral cancer morbidity and mortality rates.
Determines if remove immediately or something you need to be
concerned about and just watch, Extensive market opportunity - the
test also could be used by family doctors, hygienists, or ear,
nose, and throat specialists Copyright 2014 LED Medical Diagnostics
Inc. | 14
Slide 15
2014 Strategic Plan New executive management team with current
CEO transitioning to lead future product development Expansion of
sales, marketing & operations teams in the US in FY14 Atlanta
office established Optimization of current dealer relationships and
expansion of VELscope sale channels via non-exclusive dealers
across North America Major imaging product diversification strategy
underway Significant revenue growth with expectation that majority
of new revenues/margin anticipated from new digital imaging
products during FY14 Increased investment in R&D new product /
IP in FY14 Copyright 2014 LED Medical Diagnostics Inc. | 15
Slide 16
Six Month Milestones APR 3, 2014: Distribution partnership with
Samsung subsidiary Ray Co. APR 3, 2014: Founding of LED Imaging
Division JAN 21, 2014: Sign Patterson Dental - 85 branch offices
across USA and over 1,500 sales reps JAN 14, 2014 : Agreement with
BC Cancer Agency/Genome British Columbia (Genome BC) to create and
commercialize a progressionrisk assessment test for oral cancer.
The test is based on a quantifiable genetic phenomenon known as
Loss of Heterozygosity - the first of its kind for oral cancer DEC
10, 2013: Sign Benco Dental - More than 35,000 customers across the
country and maintains an excellent reputation in the dental
industry. DEC 3, 2013: Sign Burkhart Dental - one of the most
respected dental distributors in the United States for over 125
years OCT 29, 2013: Sign Sinclair Dental - fastest growing,
full-service dental supply companies in Canada. Sinclair has an
experienced team of over 500 individuals operating within 10
regional offices. Copyright 2014 LED Medical Diagnostics Inc. | 16
We are executing quickly
Slide 17
Capital Structure* Founded 2003 - $50MM in non-dilutive capital
via government grants, mainly the NIH/BCCS Paid in private capital:
$30MM Common Shares outstanding: 73.8MM Option outstanding 6.4MM
(price range from $0.30 to $0.54) DSUs outstanding 950K at $0.25
Warrants outstanding - 34MM 17,845,000 @ 0.20 (Exp. June 14, 2015)
30,800 @ 0.30 (Exp. June 21, 2014) 16,109,887 @ 0.50 (Exp. October
24, 2015) Potential proceeds of $11.6MM Fully Diluted: 115MM * All
numbers approximate Copyright 2014 LED Medical Diagnostics Inc. |
17
Slide 18
Contacts Dr. David Gane CEO [email protected] 404.414.6757
Lamar Roberts President, LED Imaging [email protected]
770.329.3652 Mark Komonoski Director of Investor Relations
[email protected] 403.470.8384 Copyright 2014 LED Medical
Diagnostics Inc. | 18